We invest and build companies to commercialize the newest technologies and accelerate innovations that are the future of health around the globe.
Our venture companies receive the full backing of SPRIM. Working under the parent company of SPRIM allows our investments to not only achieve funding, but leverage the global SPRIM organization to realize growth.
The result? Our Portfolio Companies spend less time worrying about raising capital, and more time building world-changing businesses.
TKS 1
SPRIM and Tikehau Capital joined forces to create a venture fund, TKS 1. This venture capital fund provides investment to early-stage healthcare companies. Tikehau Capital is listed on the regulated market of Euronext Paris, Compartment A (ISIN code: FR0013230612; Ticker: TKO.FP)
